Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at Dec. 31, 2019 $ 67,994 $ 526,301,281 $ (2,859,342) $ 523,509,933
Balance (in shares) at Dec. 31, 2019 67,993,797      
Share-based compensation $ 0 673,795 0 673,795
Net income (loss) 0 0 43,804,118 43,804,118
Balance at Mar. 31, 2020 $ 67,994 526,975,076 40,944,776 567,987,846
Balance (in shares) at Mar. 31, 2020 67,993,797      
Balance at Dec. 31, 2020 $ 85,568 550,951,415 (256,271,170) 294,765,813
Balance (in shares) at Dec. 31, 2020 85,568,287      
Share-based compensation $ 0 355,494 0 355,494
Common stock and warrants issued for cash, net 0 (65,000) 0 (65,000)
Exercise of pre-funded warrants issued in offering $ 13,429 0 0 13,429
Exercise of pre-funded warrants issued in offering (in shares) 13,428,500      
Exercise of Common warrants issued in offering $ 185 147,655 0 147,840
Exercise of Common warrants issued in offering (in shares) 184,800      
Restricted stock vested $ 94 (94) 0 0
Restricted stock vested (in shares) 94,350      
Net income (loss) $ 0 0 (19,066,093) (19,066,093)
Balance at Mar. 31, 2021 $ 99,276 $ 551,389,470 $ (275,337,263) $ 276,151,483
Balance (in shares) at Mar. 31, 2021 99,275,937